SCHEMBL5164082

SCHEMBL5164082

CCOc1ccc(Oc2ccc(S(=O)(=O)N3CCc4ccccc4[C@H]3OC(=O)NO)cn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 9/20 0.48
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
MMP3 P08254 3/20 0.42
MMP8 P22894 2/20 0.42
MMP2 P08253 6/20 0.41
MMP14 P50281 5/20 0.41
MMP13 P45452 4/20 0.41
ADAMTS4 O75173 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
MMP9 P14780 5/20 0.40
MMP7 P09237 4/20 0.40
MMP12 P39900 3/20 0.40
MMP15 P51511 3/20 0.40
MMP16 P51512 3/20 0.40
MMP26 Q9NRE1 3/20 0.40
MAPT P10636 3/20 0.40
ADAM17 P78536 1/20 0.40
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5162618 1.00 MMP1 (0.48) MMP1HDAC1HDAC2HDAC8MMP3
SCHEMBL5165889 0.91 MMP1 (0.47) MMP1MMP3MMP8MMP2MMP14
SCHEMBL5162223 0.91 MMP1 (0.47) MMP1MMP3MMP8MMP2MMP14
SCHEMBL5163767 0.91 MMP1 (0.47) MMP1MMP3MMP8MMP2MMP14
SCHEMBL5162042 0.91 MMP1 (0.46) MMP1MMP3MMP8MMP2MMP14
SCHEMBL5163691 0.90 MMP1 (0.55) MMP1HDAC1HDAC2HDAC8MMP3
SCHEMBL5434027 0.90 MMP1 (0.44) MMP1HDAC1HDAC2HDAC8MAPT
SCHEMBL5445330 0.90 MMP1 (0.44) MMP1HDAC1HDAC2HDAC8MAPT
SCHEMBL5165045 0.90 MMP1 (0.44) MMP1MMP3MMP8MMP2MMP14
SCHEMBL5165142 0.90 MMP1 (0.44) MMP1MMP3MMP8MMP2MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763516-A2 SUBSTITUTED TETRAHYDROISOCHINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRAGS Sanofi-Aventis Deutschland GmbH (DE) 2007-03-21 EP disclosed
WO-2006002763-A2 SUBSTITUTED TETRAHYDROISOCHINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRAGS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-01-12 WO disclosed